S&P 500   3,004.52 (+0.28%)
DOW   26,833.95 (+0.17%)
QQQ   192.22 (+0.19%)
AAPL   243.18 (+1.34%)
FB   186.19 (+2.11%)
MSFT   137.24 (+0.64%)
GOOGL   1,257.63 (+1.32%)
AMZN   1,762.17 (-0.20%)
CGC   21.75 (+2.84%)
NVDA   195.09 (-0.27%)
MU   44.66 (+0.00%)
BABA   169.92 (+0.02%)
GE   9.14 (+0.88%)
TSLA   254.68 (-0.35%)
AMD   31.36 (-0.48%)
T   37.74 (-1.13%)
F   9.21 (+1.54%)
ACB   3.67 (+2.51%)
PRI   125.75 (-0.04%)
NFLX   271.27 (+1.72%)
BAC   31.42 (+0.71%)
GILD   66.58 (+1.09%)
DIS   131.13 (-0.96%)
S&P 500   3,004.52 (+0.28%)
DOW   26,833.95 (+0.17%)
QQQ   192.22 (+0.19%)
AAPL   243.18 (+1.34%)
FB   186.19 (+2.11%)
MSFT   137.24 (+0.64%)
GOOGL   1,257.63 (+1.32%)
AMZN   1,762.17 (-0.20%)
CGC   21.75 (+2.84%)
NVDA   195.09 (-0.27%)
MU   44.66 (+0.00%)
BABA   169.92 (+0.02%)
GE   9.14 (+0.88%)
TSLA   254.68 (-0.35%)
AMD   31.36 (-0.48%)
T   37.74 (-1.13%)
F   9.21 (+1.54%)
ACB   3.67 (+2.51%)
PRI   125.75 (-0.04%)
NFLX   271.27 (+1.72%)
BAC   31.42 (+0.71%)
GILD   66.58 (+1.09%)
DIS   131.13 (-0.96%)
Log in

Proteon Therapeutics SEC Filings & 10K Form (NASDAQ:PRTO)

$0.27
-0.01 (-3.61 %)
(As of 10/23/2019 04:00 PM ET)
Today's Range
$0.27
Now: $0.27
$0.28
50-Day Range
$0.25
MA: $0.30
$0.38
52-Week Range
$0.24
Now: $0.27
$3.94
Volume86,252 shs
Average Volume804,564 shs
Market Capitalization$5.23 million
P/E RatioN/A
Dividend YieldN/A
Beta0.44

SEC Filings

Proteon Therapeutics (NASDAQ:PRTO) SEC Filings

DateFilerForm TypeView
10/10/2019
7:30 AM
Proteon Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/24/2019
3:17 PM
Proteon Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/24/2019
3:15 PM
Proteon Therapeutics (Subject)
Form 425
09/24/2019
1:04 PM
Proteon Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/24/2019
1:03 PM
Proteon Therapeutics (Subject)
Form 425
09/24/2019
10:26 AM
Proteon Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/24/2019
10:26 AM
Proteon Therapeutics (Subject)
Form 425
08/15/2019
4:00 PM
Proteon Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/07/2019
7:01 AM
Proteon Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/07/2019
7:00 AM
Proteon Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/15/2019
7:01 AM
Proteon Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/08/2019
7:02 AM
Proteon Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/08/2019
7:01 AM
Proteon Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/15/2019
3:30 PM
Proteon Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/12/2019
7:10 AM
Proteon Therapeutics (Filer)
Form 10-K/A
03/28/2019
7:00 AM
Proteon Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/18/2019
7:15 AM
Burke Steven Keith (Reporting)
Proteon Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/14/2019
4:04 PM
Proteon Therapeutics (Filer)
Form S-1
Registration statement under Securities Act of 1933  
03/13/2019
7:01 AM
Proteon Therapeutics (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
03/13/2019
7:00 AM
Proteon Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/07/2019
11:15 PM
Proteon Therapeutics (Filer)
Form EFFECT
02/04/2019
7:00 AM
NOYES TIMOTHY P (Reporting)
Proteon Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/23/2019
3:20 PM
Gottlieb Daniel Philip (Reporting)
Proteon Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/23/2019
3:20 PM
Proteon Therapeutics (Issuer)
Toner E. Scott (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/23/2019
3:19 PM
Kowalsky Matthew Paul (Reporting)
Proteon Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/23/2019
3:19 PM
Hartman Bradley J (Reporting)
Proteon Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/23/2019
3:18 PM
Eldridge, George Arthur (Reporting)
Proteon Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/23/2019
3:17 PM
Burke Steven Keith (Reporting)
Proteon Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/03/2019
3:31 PM
Proteon Therapeutics (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
01/03/2019
7:20 AM
Proteon Therapeutics (Issuer)
Toner E. Scott (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/03/2019
7:19 AM
Kowalsky Matthew Paul (Reporting)
Proteon Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/03/2019
7:19 AM
Eldridge, George Arthur (Reporting)
Proteon Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/03/2019
7:19 AM
Burke Steven Keith (Reporting)
Proteon Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/18/2018
7:39 AM
Proteon Therapeutics (Filer)
Form S-3
Registration statement under Securities Act of 1933  
11/07/2018
7:02 AM
Proteon Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/07/2018
7:01 AM
Proteon Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/06/2018
3:57 PM
New Leaf Biopharma Opportunities II, L.P. (Filed by)
Proteon Therapeutics (Subject)
Form SC 13G
08/07/2018
7:02 AM
Proteon Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/07/2018
7:01 AM
Proteon Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/02/2018
3:20 PM
Hartman Bradley J (Reporting)
Proteon Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/02/2018
3:15 PM
Hartman Bradley J (Reporting)
Proteon Therapeutics (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
07/03/2018
7:24 AM
Proteon Therapeutics (Issuer)
Toner E. Scott (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/03/2018
7:20 AM
Kowalsky Matthew Paul (Reporting)
Proteon Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/03/2018
7:19 AM
Eldridge, George Arthur (Reporting)
Proteon Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/03/2018
7:19 AM
Burke Steven Keith (Reporting)
Proteon Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/12/2018
1:45 PM
LEFF JONATHAN S (Reporting)
Proteon Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/12/2018
1:43 PM
DEERFIELD MANAGEMENT COMPANY, L.P. (0001009258) (Reporting)
Flynn James E (Reporting)
Proteon Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/11/2018
3:34 PM
Kingsley Stuart A (Reporting)
Proteon Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/11/2018
3:33 PM
HASTINGS PAUL J (Reporting)
Proteon Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/11/2018
3:33 PM
Haines Timothy (Reporting)
Proteon Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/11/2018
3:32 PM
Freund John Gordon (Reporting)
Proteon Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/11/2018
3:31 PM
Canute Scott A (Reporting)
Proteon Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/09/2018
7:10 AM
Proteon Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/09/2018
7:01 AM
Proteon Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/08/2018
6:10 AM
Proteon Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/26/2018
3:30 PM
Proteon Therapeutics (Filer)
Form DEF 14A
03/28/2018
7:00 AM
Proteon Therapeutics (Filer)
Form 10-K/A
03/14/2018
4:01 PM
Proteon Therapeutics (Filer)
Form 424B3
03/14/2018
4:00 PM
Proteon Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/14/2018
7:01 AM
Proteon Therapeutics (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
03/14/2018
7:00 AM
Proteon Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/05/2018
4:00 PM
Proteon Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/20/2018
7:15 AM
NOYES TIMOTHY P (Reporting)
Proteon Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/16/2018
7:15 AM
NOYES TIMOTHY P (Reporting)
Proteon Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/14/2018
4:14 PM
Proteon Therapeutics (Subject)
RA CAPITAL MANAGEMENT, LLC (Filed by)
Form SC 13G
02/13/2018
3:34 PM
INTERSOUTH PARTNERS VI LP (Filed by)
Proteon Therapeutics (Subject)
Form SC 13G/A
02/09/2018
7:16 AM
NOYES TIMOTHY P (Reporting)
Proteon Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/18/2018
4:17 PM
Proteon Therapeutics (Issuer)
Toner E. Scott (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/18/2018
4:17 PM
Kowalsky Matthew Paul (Reporting)
Proteon Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/18/2018
4:17 PM
Gottlieb Daniel Philip (Reporting)
Proteon Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/18/2018
4:16 PM
Eldridge, George Arthur (Reporting)
Proteon Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/18/2018
4:16 PM
Burke Steven Keith (Reporting)
Proteon Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/17/2018
4:01 PM
NOYES TIMOTHY P (Reporting)
Proteon Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/04/2018
3:46 PM
Proteon Therapeutics (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
01/03/2018
7:17 AM
Proteon Therapeutics (Issuer)
Toner E. Scott (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/03/2018
7:16 AM
Kowalsky Matthew Paul (Reporting)
Proteon Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/03/2018
7:16 AM
Eldridge, George Arthur (Reporting)
Proteon Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/03/2018
7:15 AM
Burke Steven Keith (Reporting)
Proteon Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/18/2017
4:11 PM
Burke Steven Keith (Reporting)
Proteon Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/15/2017
4:01 PM
NOYES TIMOTHY P (Reporting)
Proteon Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/04/2017
4:17 PM
Deerfield International Master Fund, L.P. (Reporting)
DEERFIELD MANAGEMENT CO (Reporting)
Deerfield Mgmt L.P. (Reporting)
DEERFIELD PARTNERS, L.P. (Reporting)
Flynn James E (Reporting)
Proteon Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/04/2017
4:16 PM
Flynn James E (Filed by)
Proteon Therapeutics (Subject)
Form SC 13D/A
This page was last updated on 10/23/2019 by MarketBeat.com Staff

Featured Article: Buy-Side Analysts

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel